Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-2-6
pubmed:abstractText
Bcl-2 inhibitor of transcription (Bit1) is a mitochondrial protein that functions as a peptidyl-tRNA hydrolase, but, when released into the cytoplasm, it elicits apoptosis. The proapoptotic function is uniquely counteracted by integrin-mediated cell attachment. We generated a conditional KO mouse of the Bit1 gene by using the Cre-LoxP recombination system. Bit1-null mice were born alive but with some developmental abnormalities. They developed a runting syndrome after birth and died within the first 2 weeks. Cultured fibroblasts from the Bit1-null embryos [mouse embryo fibroblasts (MEFs)] were more resistant to cell death induced by loss of attachment to extracellular matrix (anoikis) than cells from the wild-type or heterozygous littermates. MEFs and tissues from Bit1 KO mice displayed a marked increase in Erk phosphorylation. Knocking down Bit1 expression in cultured cells resulted in increased Erk activation, and partially knocking down Erk reversed the increased anoikis resistance of Bit1 knockdown. The enhanced Erk activation was associated with decreased Erk phosphatase activity. These studies establish the physiological significance of Bit1 activity and begin to delineate a Bit1 signaling pathway that acts through Erk regulation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-10206983, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-10627275, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-10644690, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-10702794, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-10712927, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-10810093, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-10831834, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-11533257, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-12475929, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-12783869, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-12892714, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-14660562, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-15006356, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-15186772, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-15372110, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-15923641, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-16413470, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-17418118, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-9649497, http://linkedlifedata.com/resource/pubmed/commentcorrection/18218778-9836645
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1528-32
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Anoikis effector Bit1 negatively regulates Erk activity.
pubmed:affiliation
Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural